Dhingra K - Search Results

1

Phase II study of deoxyspergualin in metastatic breast cancer.

Dhingra K, Valero V, Gutierrez L, Theriault R, Booser D, Holmes F, Buzdar A, Fraschini G, Hortobagyi G. Dhingra K, et al. Invest New Drugs. 1994;12(3):235-41. doi: 10.1007/BF00873965. Invest New Drugs. 1994. PMID: 7896543 Clinical Trial.

2

Phase II trial of 10-EDAM in the treatment of metastatic breast cancer.

Beinart GA, Gonzalez-Angulo AM, Broglio K, Frye D, Walters R, Holmes FA, Gunale S, Booser D, Rosenthal J, Dhingra K, Young JA, Hortobagyi GN. Beinart GA, et al. Among authors: dhingra k. Cancer Chemother Pharmacol. 2007 Jun;60(1):61-7. doi: 10.1007/s00280-006-0348-9. Epub 2006 Sep 29. Cancer Chemother Pharmacol. 2007. PMID: 17009032 Clinical Trial.

3

Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in metastatic breast cancer.

Dhingra K, Frye D, Newman RA, Walters R, Theriault R, Fraschini G, Smith T, Buzdar A, Hortobagyi GN. Dhingra K, et al. Clin Cancer Res. 1995 Jul;1(7):691-7. Clin Cancer Res. 1995. PMID: 9816034 Clinical Trial.

4

Phase II study of paclitaxel in patients with metastatic breast carcinoma refractory to standard chemotherapy.

Rivera E, Holmes FA, Frye D, Valero V, Theriault RL, Booser D, Walters R, Buzdar AU, Dhingra K, Fraschini G, Hortobagyi GN. Rivera E, et al. Among authors: dhingra k. Cancer. 2000 Dec 1;89(11):2195-201. doi: 10.1002/1097-0142(20001201)89:11<2195::aid-cncr7>3.0.co;2-w. Cancer. 2000. PMID: 11147589 Clinical Trial.

5

Phase I study of vinorelbine and paclitaxel by 3-hour simultaneous infusion with and without granulocyte colony-stimulating factor support in metastatic breast carcinoma.

Ibrahim NK, Buzdar AU, Valero V, Dhingra K, Willey J, Hortobagyi GN. Ibrahim NK, et al. Among authors: dhingra k. Cancer. 2001 Feb 15;91(4):664-71. Cancer. 2001. PMID: 11241232 Clinical Trial.

6

Phase I clinical and pharmacological study of suppression of human antimouse antibody response to monoclonal antibody L6 by deoxyspergualin.

Dhingra K, Fritsche H, Murray JL, LoBuglio AF, Khazaeli MB, Kelley S, Tepper MA, Grasela D, Buzdar A, Valero V, et al. Dhingra K, et al. Cancer Res. 1995 Jul 15;55(14):3060-7. Cancer Res. 1995. PMID: 7606728 Clinical Trial.

7

Genetic changes in breast cancer--consequences for therapy?

Dhingra K, Hittelman WN, Hortobagyi GN. Dhingra K, et al. Gene. 1995 Jun 14;159(1):59-63. doi: 10.1016/0378-1119(94)00560-f. Gene. 1995. PMID: 7607573 Review.

8

Suppression of human anti-mouse antibody response to murine monoclonal antibody L6 by deoxyspergualin: a phase I study.

Dhingra K, Fritsche H, Murray JL, LoBuglio AF, Khazaeli MB, Kelley S, Tepper M, Greene D, Booser D, Buzdar A, et al. Dhingra K, et al. Adv Exp Med Biol. 1994;353:193-202. doi: 10.1007/978-1-4615-2443-4_18. Adv Exp Med Biol. 1994. PMID: 7985538 Clinical Trial. No abstract available.

9

Paclitaxel: severe mucocutaneous toxicity in a patient with hyperbilirubinemia.

Payne JY, Holmes F, Cohen PR, Gagel R, Buzdar A, Dhingra K. Payne JY, et al. Among authors: dhingra k. South Med J. 1996 May;89(5):542-5. doi: 10.1097/00007611-199605000-00022. South Med J. 1996. PMID: 8638189

10

Critical evaluation of prognostic factors.

Dhingra K, Hortobagyi GN. Dhingra K, et al. Semin Oncol. 1996 Aug;23(4):436-45. Semin Oncol. 1996. PMID: 8757270 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

209 results

Search Page

Filters